About us

Why do we focus on product’s safety?

Why do so many surprises occur in the post-marketing phase despite modern methods of drug development, sophisticated medicine and high technology? Are they avoidable?
The knowledge of safety is often incomplete, when a product is introduced to the market. There is some probability of unexpected events during the entire marketing period, which can cause a negative impact on product’s safety.

What do we think about the integration of efficacy and safety approaches?